Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
12
×
boston blog main
life sciences
national blog main
boston top stories
san francisco blog main
boston
clinical trials
fda
san francisco top stories
cancer
deals
national top stories
startups
biotech ipos
cancer diagnostics
freenome
grail
investing
ipo
liquid biopsy
medical device
national
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
rare disease drugs
san diego blog main
san diego top stories
tc
thrive earlier detection
vc
480 biomedical
abbvie
accent therapeutics
actavalon
acute myeloid leukemia
aducanumab
What
developing
12
×
company
ipo
based
medicines
therapeutics
million
new
raised
treat
fda
medical
public
startup
tests
aims
analysis
announced
betting
biotech
blood
called
cancer
comes
drug
fund
genetic
medicine
plans
raises
technology
week
according
achieve
acquired
acquires
acquisition
activity
addition
affects
Language
unset
12
×
Current search:
biotech
×
developing
×
unset
×
@tech.eu
1 year ago
Want to live longer? This Berlin startup aims to bring you back from the dead
@techcrunch.com
2 years ago
Sirona Medical Acquires Nines AI’s algorithms to rebuild radiology’s IT from the ground up
@techcrunch.com
2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@techcrunch.com
2 years ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@tech.eu
3 years ago
Belgian startup BioStrand raises €2 million to disrupt genetic data analysis
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds